Vincentage Pharma Co., Ltd

This early study tested how a single dose of an experimental obesity medication called VCT220 is processed by the body in people with moderate kidney problems compared to people with normal kidney function. Sixteen participants received one pill, and researchers measured drug lev…

This early-stage study checked how two common medications (an antibiotic and an antifungal) might change how the body processes an experimental drug called VCT220, which is being developed for weight management. It involved 32 healthy volunteers to see if these other drugs increa…

This early-stage study aimed to understand how a new oral drug for obesity, called VCT220, might interact with three common medications (repaglinide, rosuvastatin, and digoxin). It enrolled 24 healthy, overweight, and obese volunteers to see if VCT220 changes how the body process…